This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Han, J.-w. Articles by Goldmacher, V. S. Search for Related Content PubMed PubMed Citation Articles by Han, J.-w. Articles by Goldmacher, V. S.

p53 Status Affects the Rate of the Onset but not the Overall Extent of Doxorubicin-induced Cell Death in Rat-1 Fibroblasts Constitutively Expressing c-Myc

Apoptosis Technology, Inc., Cambridge, Massachusetts 02139-4239

To better understand the effects of p53 on the process of DNA damage-induced cell death, we examined the influence of p53 status on the rate of the onset and the overall extent of cell death induced by doxorubicin. We performed this study with Rat-1 fibroblasts, with Rat-1/myc cells which constitutively express c-Myc, and with Rat-1/myc/p53His175 cells derived from Rat-1/myc cells, which, in addition, express the full-length dominant-negative p53His175 mutant gene. The p53His175 mutant suppresses the transactivation function of endogenous p53 in these cells. In contrast to the parental Rat-1 cells, which exhibited only low levels of apoptosis within the first 24 h of treatment with 0.1 to 1 µM doxorubicin, similarly treated Rat-1/myc cells underwent massive and rapid apoptosis. Introduction of p53His175 into Rat-1/myc cells reversed this effect, indicating that Myc-accelerated doxorubicin-induced apoptosis requires functional p53. However, when the overall extent of cell death was measured using clonogenic assays, we found that greater than 90% of cells did not survive upon a 24-h pretreatment with doxorubicin at a concentration as low as 0.1 µM. Moreover, the effect of doxorubicin on all three cell lines was similar, irrespective of their p53 or c-Myc status. Taken together, our experiments indicate that: (a) constitutive expression of c-Myc accelerates the onset of doxorubicin-induced apoptosis in Rat-1 fibroblasts; (b) wild-type p53 function is necessary for this acceleration; and (c) neither overexpression of c-Myc nor the p53 status influences the overall extent of doxorubicin-induced cell death.

¹ To whom requests for reprints should be addressed, at Apoptosis Technology, Inc., 148 Sidney St., Cambridge, MA 02139-4239. Phone: (617) 497-1113; Fax: (617) 497-5406; E-mail: jia-wen_han@immunogen.ccmail.compuserve.com.

Received 6/ 3/96. Accepted 10/31/96.

This article has been cited by other articles:

				J. F. Kurland and W. P. Tansey Myc-Mediated Transcriptional Repression by Recruitment of Histone Deacetylase Cancer Res., May 15, 2008; 68(10): 3624 - 3629. [Abstract] [Full Text] [PDF]

				S. Bhana and D. R. Lloyd The role of p53 in DNA damage-mediated cytotoxicity overrides its ability to regulate nucleotide excision repair in human fibroblasts Mutagenesis, January 1, 2008; 23(1): 43 - 50. [Abstract] [Full Text] [PDF]

				A. D. Colevas, J. M. Brown, S. Hahn, J. Mitchell, K. Camphausen, and C. N. Coleman Development of Investigational Radiation Modifiers J Natl Cancer Inst, May 7, 2003; 95(9): 646 - 651. [Full Text] [PDF]

				G. Laurent and J.-P. Jaffrezou Signaling pathways activated by daunorubicin Blood, August 15, 2001; 98(4): 913 - 924. [Abstract] [Full Text] [PDF]

				A. Skaletskaya, L. M. Bartle, T. Chittenden, A. L. McCormick, E. S. Mocarski, and V. S. Goldmacher A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation PNAS, June 20, 2001; (2001) 141108798. [Abstract] [Full Text] [PDF]

				R. G. Deschesnes, J. Huot, K. Valerie, and J. Landry Involvement of p38 in Apoptosis-associated Membrane Blebbing and Nuclear Condensation Mol. Biol. Cell, June 1, 2001; 12(6): 1569 - 1582. [Abstract] [Full Text] [PDF]

				X.-H. Yang, T. L. Sladek, X. Liu, B. R. Butler, C. J. Froelich, and A. D. Thor Reconstitution of Caspase 3 Sensitizes MCF-7 Breast Cancer Cells to Doxorubicin- and Etoposide-induced Apoptosis Cancer Res., January 1, 2001; 61(1): 348 - 354. [Abstract] [Full Text]

				C. G. Ferreira, S. W. Span, G. J. Peters, F. A. E. Kruyt, and G. Giaccone Chemotherapy Triggers Apoptosis in a Caspase-8-dependent and Mitochondria-controlled Manner in the Non-Small Cell Lung Cancer Cell Line NCI-H460 Cancer Res., December 1, 2000; 60(24): 7133 - 7141. [Abstract] [Full Text]

				Y. Nieto, P. J. Cagnoni, S. Nawaz, E. J. Shpall, R. Yerushalmi, B. Cook, P. Russell, J. McDermit, J. Murphy, S. I. Bearman, et al. Evaluation of the Predictive Value of Her-2/neu Overexpression and p53 Mutations in High-Risk Primary Breast Cancer Patients Treated With High-Dose Chemotherapy and Autologous Stem-Cell Transplantation J. Clin. Oncol., May 10, 2000; 18(10): 2070 - 2080. [Abstract] [Full Text] [PDF]

				L. A. Allan, T. Duhig, M. Read, and M. Fried The p21WAF1/CIP1 Promoter Is Methylated in Rat-1 Cells: Stable Restoration of p53-Dependent p21WAF1/CIP1 Expression after Transfection of a Genomic Clone Containing the p21WAF1/CIP1 Gene Mol. Cell. Biol., February 15, 2000; 20(4): 1291 - 1298. [Abstract] [Full Text]

				M. Giuliano, M. Lauricella, G. Calvaruso, M. Carabillo, S. Emanuele, R. Vento, and G. Tesoriere The Apoptotic Effects and Synergistic Interaction of Sodium Butyrate and MG132 in Human Retinoblastoma Y79 Cells Cancer Res., November 1, 1999; 59(21): 5586 - 5595. [Abstract] [Full Text] [PDF]

				J. M. Brown and B. G. Wouters Apoptosis, p53, and Tumor Cell Sensitivity to Anticancer Agents Cancer Res., April 1, 1999; 59(7): 1391 - 1399. [Abstract] [Full Text] [PDF]

				G. Evan and T. Littlewood A Matter of Life and Cell Death Science, August 28, 1998; 281(5381): 1317 - 1322. [Abstract] [Full Text]

				S. D'Atri, L. Tentori, P. M. Lacal, G. Graziani, E. Pagani, E. Benincasa, G. Zambruno, E. Bonmassar, and J. Jiricny Involvement of the Mismatch Repair System in Temozolomide-Induced Apoptosis Mol. Pharmacol., August 1, 1998; 54(2): 334 - 341. [Abstract] [Full Text]

				A. Skaletskaya, L. M. Bartle, T. Chittenden, A. L. McCormick, E. S. Mocarski, and V. S. Goldmacher A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation PNAS, July 3, 2001; 98(14): 7829 - 7834. [Abstract] [Full Text] [PDF]